Pharmacina Ltd - Dormant accounts - members and to registrar (filleted) 18.1.1

REGISTERED NUMBER: 04445887 (England and Wales)

REPORT OF THE DIRECTOR AND

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MAY 2019

FOR

PHARMACINA LTD

Page

Company Information

1

Report of the Director

2

Balance Sheet

3

Notes to the Financial Statements

4

DIRECTOR:

Dr M Rad-Niknam

REGISTERED OFFICE:

584 Wellsway

Bath

Somerset

BA2 2UE

REGISTERED NUMBER:

04445887 (England and Wales)

ACCOUNTANTS:

JSH Accountancy Limited

584 Wellsway

Bath

Somerset

BA2 2UE

The director presents his report with the financial statements of the company for the year ended 31 May 2019.

DIRECTOR

Dr M Rad-Niknam held office during the whole of the period from 1 June 2018 to the date of this report.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small

companies.

ON BEHALF OF THE BOARD:

Dr M Rad-Niknam - Director

27 February 2020

FIXED ASSETS

Tangible assets

3

168

CURRENT ASSETS

Stocks

9,389

Cash at bank

1,080

10,469

CREDITORS

Amounts falling due within one year

4

(49,240

)

(49,240

)

NET CURRENT LIABILITIES

(38,771

)

(38,771

)

TOTAL ASSETS LESS CURRENT
LIABILITIES

(38,603

)

(38,603

)

CAPITAL AND RESERVES

Called up share capital

50,000

Retained earnings

(88,603

)

(88,603

)

SHAREHOLDERS' FUNDS

(38,603

)

(38,603

)

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the year ended 31 May 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 27 February 2020 and were signed by:

Dr M Rad-Niknam - Director

1.	STATUTORY INFORMATION

Pharmacina Ltd is a private company, limited by shares , registered in England and Wales. The company's

registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow

moving items.

3.	TANGIBLE FIXED ASSETS

Computer

equipment

£

COST

At 1 June 2018

and 31 May 2019

3,138

DEPRECIATION

At 1 June 2018

and 31 May 2019

2,970

NET BOOK VALUE

At 31 May 2019

168

At 31 May 2018

168

4.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2019

2018

£

Trade creditors

10,009

VAT

6

Directors' loan accounts

39,046

Accrued expenses

179

49,240